{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T02:02:12Z","timestamp":1768788132332,"version":"3.49.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Natural Science Funds","award":["81303247"],"award-info":[{"award-number":["81303247"]}]},{"DOI":"10.13039\/501100013286","name":"Research Fund for the Doctoral Program of Higher Education of China","doi-asserted-by":"crossref","award":["20121210120009"],"award-info":[{"award-number":["20121210120009"]}],"id":[{"id":"10.13039\/501100013286","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ethnopharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.jep.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T18:57:44Z","timestamp":1457549864000},"page":"20-29","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-\u03bab pathway"],"prefix":"10.1016","volume":"186","author":[{"given":"Hao-ping","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing-ye","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun\u2212hang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-xu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zi-chang","family":"Niu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ju-qing","family":"Ai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiu-mei","family":"Gao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jep.2016.03.015_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2015.01.005","article-title":"Buthionine Sulfoximine, an inhibitor of Glutathione biosynthesis, induces expression of soluble epoxide hydrolase and markers of cellular hypertrophy in a rat cardiomyoblast cell line: roles of the NF-kappaB and MAPK signaling pathways","volume":"82","author":"Abdelhamid","year":"2015","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.jep.2016.03.015_bib2","doi-asserted-by":"crossref","first-page":"268","DOI":"10.3181\/00379727-136-35243","article-title":"Myocardial hypertrophy resulting from low dosage Isoproterenol administration in rats","volume":"136","author":"Alderman","year":"1971","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1016\/j.jep.2016.03.015_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.chroma.2008.08.054","article-title":"The antioxidant-activity-integrated fingerprint: an advantageous tool for the evaluation of quality of herbal medicines","volume":"1208","author":"Chang","year":"2008","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.jep.2016.03.015_bib4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jep.2014.04.023","article-title":"Lipid-lowering effects of Danhong injection on hyperlipidemia rats","volume":"154","author":"Chen","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib5","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/FJC.0000000000000067","article-title":"Danhong injection inhibits the development of atherosclerosis in both Apoe(-)\/(-) and Ldlr(-)\/(-) mice","volume":"63","author":"Chen","year":"2014","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib6","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1016\/j.biocel.2013.05.037","article-title":"NF-kappaB: emerging roles in hippocampal development and function","volume":"45","author":"Crampton","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.jep.2016.03.015_bib7","doi-asserted-by":"crossref","first-page":"2852","DOI":"10.1111\/bph.13091","article-title":"The orphan receptor NOR1 participates in isoprenaline-induced cardiac hypertrophy by regulating PARP-1","volume":"172","author":"Feng","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib8","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1161\/01.CIR.0000164237.58200.5A","article-title":"Requirement of nuclear factor-kappa B in angiotensin II- and isoproterenol-induced cardiac hypertrophy in vivo","volume":"111","author":"Freund","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.jep.2016.03.015_bib9","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1146\/annurev.physiol.65.092101.142243","article-title":"Cardiac hypertrophy: the good, the bad, and the ugly","volume":"65","author":"Frey","year":"2003","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.jep.2016.03.015_bib10","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.2741\/e484","article-title":"Beta-Adrenoceptor signaling pathways mediate cardiac pathological remodeling","volume":"4","author":"Fu","year":"2012","journal-title":"Front. Biosci. (Elite Ed.)"},{"key":"10.1016\/j.jep.2016.03.015_bib11","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1291\/hypres.29.839","article-title":"Sympathetic overdrive and cardiovascular risk in the metabolic syndrome","volume":"29","author":"Grassi","year":"2006","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.jep.2016.03.015_bib12","doi-asserted-by":"crossref","first-page":"H316","DOI":"10.1152\/ajpheart.00635.2014","article-title":"Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic beta-adrenergic receptor stimulation","volume":"308","author":"Grisanti","year":"2015","journal-title":"Am. J. Physiol.-Heart Circ. Physiol."},{"key":"10.1016\/j.jep.2016.03.015_bib13","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1253\/circj.CJ-15-0589","article-title":"Natriuretic peptides and Cardiometabolic health","volume":"79","author":"Gupta","year":"2015","journal-title":"Circ. J.: Off. J. Jpn. Circ. Soc."},{"key":"10.1016\/j.jep.2016.03.015_bib14","doi-asserted-by":"crossref","unstructured":"He, T., Guan, A., Shi, Y., Ge, Z., Dai, H., 2015. Mitochondrial coupling factor 6 upregulation in hypertension-induced cardiac hypertrophy. Herz","DOI":"10.1007\/s00059-015-4301-8"},{"key":"10.1016\/j.jep.2016.03.015_bib15","doi-asserted-by":"crossref","first-page":"a001271","DOI":"10.1101\/cshperspect.a001271","article-title":"NF-kappaB in the nervous system","volume":"1","author":"Kaltschmidt","year":"2009","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.jep.2016.03.015_bib16","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bbi.2014.10.007","article-title":"beta2-Adrenergic receptors in immunity and inflammation: stressing NF-kappaB","volume":"45","author":"Kolmus","year":"2015","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.jep.2016.03.015_bib17","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1111\/jcmm.12567","article-title":"High-density lipoprotein inhibits mechanical stress-induced cardiomyocyte autophagy and cardiac hypertrophy through angiotensin II type 1 receptor-mediated PI3K\/Akt pathway","volume":"19","author":"Lin","year":"2015","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.jep.2016.03.015_bib18","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jpba.2012.12.013","article-title":"Quantitative analysis combined with chromatographic fingerprint for comprehensive evaluation of Danhong injection using HPLC-DAD","volume":"76","author":"Liu","year":"2013","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jep.2016.03.015_bib19","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/j.jacc.2006.05.020","article-title":"Natriuretic peptides and cardiac hypertrophy","volume":"48","author":"London","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jep.2016.03.015_bib20","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1161\/CIRCRESAHA.116.304937","article-title":"Mechanotransduction in cardiac hypertrophy and failure","volume":"116","author":"Lyon","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.jep.2016.03.015_bib21","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1016\/j.metabol.2014.10.028","article-title":"Biomarkers of cardiovascular disease risk in women","volume":"64","author":"Manson","year":"2015","journal-title":"Metabolism: Clin. Exp."},{"key":"10.1016\/j.jep.2016.03.015_bib22","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.yjmcc.2010.10.021","article-title":"The p38 mitogen-activated protein kinase pathway--a potential target for intervention in infarction, hypertrophy, and heart failure","volume":"51","author":"Marber","year":"2011","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jep.2016.03.015_bib23","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1093\/ajh\/2.2.128","article-title":"Left ventricular hypertrophy as a factor in arrhythmias and sudden death","volume":"2","author":"McLenachan","year":"1989","journal-title":"Am J. Hypertens."},{"key":"10.1016\/j.jep.2016.03.015_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nucmedbio.2014.09.008","article-title":"N-[C-11]-methyl-Hydroxyfasudil is a potential biomarker of cardiac hypertrophy","volume":"42","author":"Moreau","year":"2015","journal-title":"Nucl. Med. Biol."},{"key":"10.1016\/j.jep.2016.03.015_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1006\/jmcc.2000.1332","article-title":"Beta-adrenergic cardiac hypertrophy is mediated primarily by the beta(1)-subtype in the rat heart","volume":"33","author":"Morisco","year":"2001","journal-title":"J. Mol. Cell. Cardiol."},{"key":"10.1016\/j.jep.2016.03.015_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1042\/CS20070430","article-title":"MAPK signalling in cardiovascular health and disease: molecular mechanisms and therapeutic targets","volume":"115","author":"Muslin","year":"2008","journal-title":"Clin. Sci."},{"key":"10.1016\/j.jep.2016.03.015_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/S0735-1097(96)00277-X","article-title":"Marked expression of plasma brain Natriuretic peptide is a special feature of hypertrophic obstructive cardiomyopathy","volume":"28","author":"Nishigaki","year":"1996","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jep.2016.03.015_bib28","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.jdiacomp.2015.04.012","article-title":"PPARgamma\u2013PI3K\/AKT-NO signal pathway is involved in Cardiomyocyte hypertrophy induced by high glucose and insulin","volume":"29","author":"Peng","year":"2015","journal-title":"J. Diabetes Complic."},{"key":"10.1016\/j.jep.2016.03.015_bib29","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1161\/CIRCRESAHA.116.306082","article-title":"Microdomain switch of cGMP-regulated Phosphodiesterases leads to ANP-induced augmentation of beta-adrenoceptor-stimulated contractility in early cardiac hypertrophy","volume":"116","author":"Perera","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.jep.2016.03.015_bib30","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/nrm2083","article-title":"Integrating cell-signalling pathways with NF-kappaB and IKK function","volume":"8","author":"Perkins","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.jep.2016.03.015_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.jep.2014.08.023","article-title":"Study of the protective mechanisms of Compound Danshen Tablet (Fufang Danshen Pian) against myocardial ischemia\/reperfusion injury via the Akt-eNOS signaling pathway in rats","volume":"156","author":"Ren-an","year":"2014","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phrs.2009.11.012","article-title":"Molecular targets and regulators of cardiac hypertrophy","volume":"61","author":"Rohini","year":"2010","journal-title":"Pharmacol. Res: Off. J. Italian Pharmacol. Soc."},{"key":"10.1016\/j.jep.2016.03.015_bib33","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1136\/heartjnl-2013-305402","article-title":"MicroRNAs in cardiovascular disease: an introduction for clinicians","volume":"101","author":"Romaine","year":"2015","journal-title":"Heart"},{"key":"10.1016\/j.jep.2016.03.015_bib34","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.jacc.2005.12.081","article-title":"Association of atrial natriuretic peptide and type a natriuretic peptide receptor gene polymorphisms with left ventricular mass in human essential hypertension","volume":"48","author":"Rubattu","year":"2006","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.jep.2016.03.015_bib35","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1600-065X.2011.01091.x","article-title":"Dimer-specific regulatory mechanisms within the NF-kappaB family of transcription factors","volume":"246","author":"Smale","year":"2012","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.jep.2016.03.015_bib36","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.drudis.2014.10.004","article-title":"Differential expression of microRNAs in ischemic heart disease","volume":"20","author":"Song","year":"2015","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.jep.2016.03.015_bib37","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/FJC.0000000000000164","article-title":"Vasorelaxant activities of Danhong injection and their differential effects on the rat abdominal aorta and mesenteric artery","volume":"65","author":"Su","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib38","first-page":"2927","article-title":"Biomarkers and heart disease","volume":"18","author":"Sun","year":"2014","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jep.2016.03.015_bib39","doi-asserted-by":"crossref","first-page":"383","DOI":"10.7150\/ijbs.7.383","article-title":"Tanshinone IIA protects against cardiac hypertrophy via inhibiting calcineurin\/NFATc3 pathway","volume":"7","author":"Tan","year":"2011","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.jep.2016.03.015_bib40","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.phymed.2011.05.007","article-title":"Antioxidant and Cardioprotective effects of Danshensu (3-(3, 4-Dihydroxyphenyl)-2-Hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats","author":"Tang","year":"2011","journal-title":"Phytomed.: Int. J. Phytother. Phytopharm. 18"},{"key":"10.1016\/j.jep.2016.03.015_bib41","first-page":"1","article-title":"Peripheral and central effects of circulating catecholamines. comprehensive","volume":"5","author":"Tank","year":"2015","journal-title":"Physiology"},{"key":"10.1016\/j.jep.2016.03.015_bib42","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jep.2010.05.038","article-title":"Carthamus tinctorius L. prevents LPS-induced TNFalpha signaling activation and cell apoptosis through JNK1\/2-NFkappaB pathway inhibition in H9c2 Cardiomyoblast cells","volume":"130","author":"Tien","year":"2010","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib43","first-page":"71","article-title":"Angiotensin receptor Neprilysin inhibitor LCZ696 attenuates cardiac remodeling and dysfunction after myocardial infarction by reducing cardiac fibrosis and hypertrophy","volume":"8","author":"von Lueder","year":"2014","journal-title":"Circulation: Heart Fail."},{"key":"10.1016\/j.jep.2016.03.015_bib44","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000339271","article-title":"Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application","volume":"122","author":"Wachter","year":"2012","journal-title":"Cardiology"},{"key":"10.1016\/j.jep.2016.03.015_bib45","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.4103\/1673-5374.139462","article-title":"Pretreatment with Danhong injection protects the brain against ischemia-reperfusion injury","volume":"9","author":"Wang","year":"2014","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.jep.2016.03.015_bib46","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1023\/A:1007131925048","article-title":"Modification of beta-adrenoceptor signal transduction pathway by genetic manipulation and heart failure","volume":"214","author":"Wang","year":"2000","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.jep.2016.03.015_bib47","doi-asserted-by":"crossref","unstructured":"Wang, Y., Gao, L.N., Cui, Y.L., Jiang, H.L., 2014b. Protective effect of danhong injection on acute hepatic failure induced by lipopolysaccharide and d-galactosamine in mice. Evidence-based complementary and alternative medicine : eCAM 2014, 153902.","DOI":"10.1155\/2014\/153902"},{"key":"10.1016\/j.jep.2016.03.015_bib48","doi-asserted-by":"crossref","unstructured":"Xiao, R.P., 2001. Beta-adrenergic signaling in the heart: dual coupling of the beta2-adrenergic receptor to G(s) and G(i) proteins. Science's STKE : signal transduction knowledge environment 2001, re15.","DOI":"10.1126\/scisignal.1042001re15"},{"key":"10.1016\/j.jep.2016.03.015_bib49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s003920050001","article-title":"Molecular basis of cardiac hypertrophy","volume":"89","author":"Yamazaki","year":"2000","journal-title":"Z. Fur Kardiol."},{"key":"10.1016\/j.jep.2016.03.015_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2015.02.023","article-title":"Inhibition of NF-kappa B activity in the hypothalamic Paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress","volume":"284","author":"Yu","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib51","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.taap.2015.02.023","article-title":"Inhibition of NF-kappaB activity in the hypothalamic paraventricular nucleus attenuates hypertension and cardiac hypertrophy by modulating cytokines and attenuating oxidative stress","volume":"284","author":"Yu","year":"2015","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"10.1016\/j.jep.2016.03.015_bib52","doi-asserted-by":"crossref","first-page":"e0124061","DOI":"10.1371\/journal.pone.0124061","article-title":"Continuing treatment with Salvia miltiorrhiza injection attenuates myocardial fibrosis in chronic iron-overloaded mice","volume":"10","author":"Zhang","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jep.2016.03.015_bib53","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/B978-0-12-384921-2.00009-4","article-title":"Beta-adrenergic receptor subtype signaling in the heart: from bench to the bedside","volume":"67","author":"Zhu","year":"2011","journal-title":"Curr. Top. Membr."}],"container-title":["Journal of Ethnopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874116301209?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378874116301209?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,16]],"date-time":"2020-05-16T15:34:16Z","timestamp":1589643256000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378874116301209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":53,"alternative-id":["S0378874116301209"],"URL":"https:\/\/doi.org\/10.1016\/j.jep.2016.03.015","relation":{},"ISSN":["0378-8741"],"issn-type":[{"value":"0378-8741","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Danhong injection attenuates isoproterenol-induced cardiac hypertrophy by regulating p38 and NF-\u03bab pathway","name":"articletitle","label":"Article Title"},{"value":"Journal of Ethnopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jep.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}